In this sense, recent studies have reported favorable effects of SIRT1 activation over pathophysiological NAFLD elements such as glycemic [113,114,115] and lipid impairment [116,117], inflammation [118], and oxidative stress [119], among others [112,120,121]. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.